TABLE 3.
Predictors of 6-Month Change in Self-Efficacy (N = 412)
Regression Coefficient | Value | LCL | UCL | p |
---|---|---|---|---|
Intercepta | 0.49 | 0.31 | 0.66 | < .001 |
Hispanic American versus European American | 0.35 | −0.01 | 0.71 | .058 |
African American versus European American | 0.35 | 0.01 | 0.69 | .045 |
Other versus European American | 0.02 | −0.38 | 0.42 | .933 |
Baseline self-efficacy | −0.26 | −0.40 | −0.13 | .001 |
Baseline decisional balance | 0.05 | −0.08 | 0.19 | .428 |
NRT-related contacts | 0.19 | 0.10 | 0.28 | < .001 |
Note. LCL = 95% lower confidence limit; UCL = 95% upper confidence limit; NRT = nicotine replacement therapy.
Intercept gives the baseline odds for European Americans.